{"id":"https://openalex.org/W1584882869","doi":"https://doi.org/10.1002/jat.3044","title":"Plasma miR\u2010208 as a useful biomarker for drug\u2010induced cardiotoxicity in rats","display_name":"Plasma miR\u2010208 as a useful biomarker for drug\u2010induced cardiotoxicity in rats","publication_year":2014,"publication_date":"2014-08-04","ids":{"openalex":"https://openalex.org/W1584882869","doi":"https://doi.org/10.1002/jat.3044","mag":"1584882869","pmid":"https://pubmed.ncbi.nlm.nih.gov/25092230"},"language":"en","primary_location":{"id":"doi:10.1002/jat.3044","doi":"https://doi.org/10.1002/jat.3044","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jat.3044","pdf_url":null,"source":{"id":"https://openalex.org/S81851855","display_name":"Journal of Applied Toxicology","issn_l":"0260-437X","issn":["0260-437X","1099-1263"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Applied Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003675418","display_name":"Yoko Nishimura","orcid":"https://orcid.org/0000-0002-2946-498X","observed_orcids":["https://orcid.org/0000-0002-2946-498X"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoko Nishimura","raw_affiliation_strings":["Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chiaki Kondo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chiaki Kondo","raw_affiliation_strings":["Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108376003","display_name":"Yuji Morikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Morikawa","raw_affiliation_strings":["Discovery Research Laboratory for Innovative Frontier Medicines Shionogi & Co., Ltd. 3\u20101\u20101 Futaba\u2010cho Toyonaka Osaka 561\u20100825 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Research Laboratory for Innovative Frontier Medicines Shionogi & Co., Ltd. 3\u20101\u20101 Futaba\u2010cho Toyonaka Osaka 561\u20100825 Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110059241","display_name":"Yutaka Tonomura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Tonomura","raw_affiliation_strings":["Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045893156","display_name":"Mikinori Torii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mikinori Torii","raw_affiliation_strings":["Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009514473","display_name":"Jyoji Yamate","orcid":"https://orcid.org/0009-0002-5544-2925","observed_orcids":["https://orcid.org/0009-0002-5544-2925"]},"institutions":[{"id":"https://openalex.org/I15807432","display_name":"Osaka Prefecture University","ror":"https://ror.org/02cf1je33","country_code":"JP","type":"education","lineage":["https://openalex.org/I15807432","https://openalex.org/I4387152983"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jyoji Yamate","raw_affiliation_strings":["Laboratory of Veterinary Pathology, Life and Environmental Sciences Osaka Prefecture University 1-58 Rinku-oraikita Izumisano Osaka 598-8531 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Veterinary Pathology, Life and Environmental Sciences Osaka Prefecture University 1-58 Rinku-oraikita Izumisano Osaka 598-8531 Japan","institution_ids":["https://openalex.org/I15807432"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028399560","display_name":"Takeki Uehara","orcid":"https://orcid.org/0000-0002-5853-9426","observed_orcids":["https://orcid.org/0000-0002-5853-9426"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeki Uehara","raw_affiliation_strings":["Global Project Management Shionogi & Co., Ltd. 12F, Hankyu Terminal Bldg., 1\u20101\u20104 Shibata Kita\u2010ku Osaka 530\u20100012 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Project Management Shionogi & Co., Ltd. 12F, Hankyu Terminal Bldg., 1\u20101\u20104 Shibata Kita\u2010ku Osaka 530\u20100012 Japan","institution_ids":["https://openalex.org/I4210118477"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003675418"],"corresponding_institution_ids":["https://openalex.org/I4210118477"],"apc_list":{"value":3940,"currency":"USD","value_usd":3940},"apc_paid":null,"fwci":6.6186,"has_fulltext":false,"cited_by_count":91,"citation_normalized_percentile":{"value":0.9746732,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"35","issue":"2","first_page":"173","last_page":"180"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.7455999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.7455999851226807,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.08510000258684158,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11962","display_name":"Cardiac Fibrosis and Remodeling","score":0.0706000030040741,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-208","display_name":"miR-208","score":0.9430000185966492},{"id":"https://openalex.org/keywords/plasma-mirna","display_name":"plasma microRNA","score":0.6029999852180481},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7730000019073486},{"id":"https://openalex.org/keywords/drug-induced-cardiotoxicity","display_name":"drug-induced cardiotoxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/circulating-biomarkers","display_name":"circulating biomarkers","score":0.7429999709129333},{"id":"https://openalex.org/keywords/isoproterenol","display_name":"isoproterenol","score":0.9559999704360962},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/cardiac-troponin","display_name":"cardiac troponin","score":0.875},{"id":"https://openalex.org/keywords/mir-1","display_name":"miR-1","score":0.9200000166893005},{"id":"https://openalex.org/keywords/mir-133a","display_name":"miR-133a","score":0.9430000185966492},{"id":"https://openalex.org/keywords/mir-133b","display_name":"miR-133b","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mir-206","display_name":"miR-206","score":1.0},{"id":"https://openalex.org/keywords/myocardial-fibrosis","display_name":"myocardial fibrosis","score":0.6909999847412109},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.36800000071525574}],"concepts":[{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.9270222187042236},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.7309537529945374},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6746959090232849},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.5553753972053528},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5365052223205566},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4893569350242615},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.48103004693984985},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3340685963630676},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2504023015499115},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.20202422142028809},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007545","descriptor_name":"Isoproterenol","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014336","descriptor_name":"Troponin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018482","descriptor_name":"Muscle, Skeletal","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D020411","descriptor_name":"Oligonucleotide Array Sequence Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D035683","descriptor_name":"MicroRNAs","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D066126","descriptor_name":"Cardiotoxicity","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jat.3044","doi":"https://doi.org/10.1002/jat.3044","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jat.3044","pdf_url":null,"source":{"id":"https://openalex.org/S81851855","display_name":"Journal of Applied Toxicology","issn_l":"0260-437X","issn":["0260-437X","1099-1263"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Applied Toxicology","raw_type":"journal-article"},{"id":"pmid:25092230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25092230","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of applied toxicology : JAT","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W144423133","https://openalex.org/W1478610489","https://openalex.org/W1523944817","https://openalex.org/W1539403009","https://openalex.org/W1970285719","https://openalex.org/W1971726501","https://openalex.org/W1983085353","https://openalex.org/W1983973523","https://openalex.org/W1999938176","https://openalex.org/W2000956788","https://openalex.org/W2014713860","https://openalex.org/W2022057640","https://openalex.org/W2024206172","https://openalex.org/W2051032563","https://openalex.org/W2104747869","https://openalex.org/W2115557844","https://openalex.org/W2132888671","https://openalex.org/W2150692944","https://openalex.org/W2153349282","https://openalex.org/W2274238704","https://openalex.org/W2399220535"],"related_works":["https://openalex.org/W2176855662","https://openalex.org/W7214988944","https://openalex.org/W2791205352","https://openalex.org/W2179979277","https://openalex.org/W1655320359","https://openalex.org/W2150692944","https://openalex.org/W2070935467","https://openalex.org/W4213425568","https://openalex.org/W2521102675","https://openalex.org/W2904760209"],"abstract_inverted_index":{"Cardiotoxicity":[0],"is":[1,21,46,196],"one":[2],"of":[3,73,94,127,139,155,175,206,218],"the":[4,55,92,136,160,179,184],"major":[5],"safety":[6],"concerns":[7],"in":[8,31,41,59,62,101,119,203,210,220],"drug":[9],"development.":[10],"Therefore,":[11],"detecting":[12],"and":[13,18,80,83,143],"monitoring":[14],"cardiotoxicity":[15,40,202,219],"throughout":[16],"preclinical":[17,221],"clinical":[19],"studies":[20],"important":[22,48],"for":[23,39,50,172,201],"pharmaceutical":[24],"companies.":[25],"The":[26],"present":[27],"study":[28],"was":[29,111,164],"conducted":[30],"order":[32],"to":[33,183,214],"explore":[34],"a":[35,51,153,197],"plasma":[36,125,137,161,199,207],"miRNA":[37,56],"biomarker":[38,200],"rats.":[42,65,204],"As":[43],"organ":[44],"specificity":[45],"an":[47],"factor":[49],"biomarker,":[52],"we":[53,90],"analyzed":[54],"microarray":[57],"dataset":[58],"55":[60],"organs/tissues":[61],"normal":[63],"male":[64],"Based":[66],"on":[67],"this":[68],"analysis,":[69],"5":[70,96],"miRNAs":[71,97],"consisting":[72],"miR-208":[74,110,162,195,208],"(heart-specific),":[75],"miR-1,":[76,140],"miR-133a,":[77,141],"miR-133b":[78],"(heart":[79],"skeletal":[81,156],"muscle-specific)":[82,86],"miR-206":[84,144],"(skeletal":[85],"were":[87,145],"selected.":[88],"Next,":[89],"evaluated":[91],"usefulness":[93],"those":[95],"as":[98,152,188],"circulating":[99],"biomarkers":[100],"rats":[102,120,211],"administered":[103,121],"with":[104,122,149],"single-dose":[105],"isoproterenol":[106,176],"or":[107],"doxorubicin.":[108],"Plasma":[109],"consistently":[112],"increased":[113],"through":[114],"24":[115],"h":[116],"after":[117,147,167],"dosing":[118],"isoproterenol,":[123],"whereas":[124],"concentrations":[126],"cardiac":[128],"troponin":[129],"(cTn)":[130],"showed":[131],"transient":[132],"elevation.":[133],"In":[134],"contrast,":[135],"levels":[138,209],"miR-133a":[142],"elevated":[146,165],"treatment":[148],"doxorubicin,":[150],"probably":[151],"result":[154],"muscle":[157],"toxicity.":[158],"Additionally,":[159],"level":[163],"even":[166],"repeat-dose":[168],"administration":[169],"(once":[170],"daily":[171],"7":[173],"days)":[174],"under":[177],"which":[178],"pathological":[180],"condition":[181],"proceeded":[182],"sub-chronic":[185],"phase":[186],"such":[187],"fibrosis.":[189],"Thus,":[190],"our":[191],"data":[192],"suggest":[193],"that":[194],"promising":[198],"Monitoring":[205],"may":[212],"lead":[213],"more":[215],"accurate":[216],"evaluation":[217],"studies.":[222]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}